Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study
Gridelli, Cesare, Dr, Gallo, Ciro, Prof, Ceribelli, Anna, MD, Gebbia, Vittorio, MD, Gamucci, Teresa, MD, Ciardiello, Fortunato, Prof, Carozza, Francesco, MD, Favaretto, Adolfo, MD, Daniele, Bruno, MD, Galetta, Domenico, MD, Barbera, Santi, MD, Rosetti, Francesco, MD, Rossi, Antonio, Maione, Paolo, MD, Cognetti, Francesco, MD, Testa, Antonio, MD, Di Maio, Massimo, MD, Morabito, Alessandro, MD, Perrone, Francesco, MD
Published in The lancet oncology (01.06.2007)
Published in The lancet oncology (01.06.2007)
Get full text
Journal Article